Collins had an aggressive cancer that responded well to a certain regimen of prompt chemotherapy
"That was really pretty devastating "recalls Collins,66
But a severe shortage of one of the key drugs,he learned,would force a switch to less effective drugs to avoid interrupting treatment
His prognosis would worsen without the drug,cytarabine,from about a 70 percent chance of staying in remission for 10 years to "a tossup"
a retired Viterbo University chemistry professor